Dynamic production of hypoxia-inducible factor-1α in early transplanted islets

被引:80
|
作者
Miao, G.
Ostrowski, R. P.
Mace, J.
Hough, J.
Hopper, A.
Peverini, R.
Chinnock, R.
Zhang, J.
Hathout, E. [1 ]
机构
[1] Loma Linda Univ, Sch Med, Dept Pediat, Islet Transplant Lab, Loma Linda, CA 92350 USA
[2] Loma Linda Univ, Sch Med, Dept Physiol, Loma Linda, CA 92350 USA
[3] Loma Linda Univ, Sch Med, Dept Anat, Loma Linda, CA USA
关键词
apoptosis; hypoxia; hypoxia-inducible factor; islet failure; islet transplantation; type; 1; diabetes;
D O I
10.1111/j.1600-6143.2006.01541.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
More than half of transplanted beta-cells undergo apoptotic cell death triggered by nonimmunological factors within a few days after transplantation. To investigate the dynamic hypoxic responses in early transplanted islets, syngeneic islets were transplanted under the kidney capsule of balb/c mice. Hypoxia-inducible factor-1 alpha (HIF-1 alpha) was strongly expressed at post-transplant day (POD) 1, increased on POD 3, and gradually diminished on POD 14. Insulin secretion decreased on POD 3 in association with a significant increase of HIF-1 alpha-related beta-cell death, which can be suppressed by short-term hyperbaric oxygen therapy. On POD 7, apoptosis was not further activated by continually produced HIF-1 alpha. In contrast, improvement of nerve growth factor and duodenal homeobox factor-1 (PDx-1) production resulted in islet graft recovery and remodeling. In addition, significant activation of vascular endothelial growth factor in islet grafts on POD 7 correlated with development of massive newly formed microvessels, whose maturation is advanced on POD 14 with gradual diminution of HIF-1 alpha. We conclude that (1) transplanted islets strongly express HIF-1 alpha in association with beta-cell death and decreased insulin production until adequate revascularization is established and (2) early suppression of HIF-1 alpha results in less beta-cell death thereby minimizing early graft failure.
引用
收藏
页码:2636 / 2643
页数:8
相关论文
共 50 条
  • [21] The hypoxia-inducible factor-1α is a negative factor for tumor therapy
    Unruh, A
    Ressel, A
    Mohamed, HG
    Johnson, RS
    Nadrowitz, R
    Richter, E
    Katschinski, DM
    Wenger, RH
    ONCOGENE, 2003, 22 (21) : 3213 - 3220
  • [22] The hypoxia-inducible factor-1α is a negative factor for tumor therapy
    Annika Unruh
    Anke Ressel
    Hamid G Mohamed
    Randall S Johnson
    Roger Nadrowitz
    Eckart Richter
    Dörthe M Katschinski
    Roland H Wenger
    Oncogene, 2003, 22 : 3213 - 3220
  • [23] Inhibitor of nuclear factor-kappaB alpha derepresses hypoxia-inducible factor-1 during moderate hypoxia by sequestering factor inhibiting hypoxia-inducible factor from hypoxia-inducible factor 1α
    Shin, Dong Hoon
    Li, Shan Hua
    Yang, Seung-Won
    Lee, Byung Lan
    Lee, Myung Kyu
    Park, Jong-Wan
    FEBS JOURNAL, 2009, 276 (13) : 3470 - 3480
  • [24] Hypoxia-inducible factor-1 as a therapeutic target in cancer
    Tang, Ceen-Ming
    Yu, Jun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (03) : 401 - 405
  • [25] Tetrathiomolybdate mediates the degradation of hypoxia-inducible factor-1α
    Kim, Kyu Kwang
    Abelman, Sarah
    Yano, Naohiro
    Ribeiro, Jennifer R.
    Singh, Rakesh K.
    Tipping, Marla
    Moore, Richard G.
    GYNECOLOGIC ONCOLOGY, 2015, 139 (03) : 590 - 590
  • [26] Hypoxia-inducible factor-1 regulation and therapeutic implication
    Rustum, Youcef M.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 26 : S9 - S9
  • [27] Living kidney donors and hypoxia-inducible factor-1α
    Baan, C
    van Gelder, T
    Peeters, A
    Mol, W
    Niesters, H
    Weimar, W
    IJzermans, J
    TRANSPLANTATION, 2003, 75 (04) : 570 - 571
  • [28] Hypoxia-inducible factor-1 regulation of myeloid cells
    Stothers, C. L.
    Luan, L.
    Fensterheim, B. A.
    Bohannon, J. K.
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2018, 96 (12): : 1293 - 1306
  • [29] The Role of Hypoxia-inducible Factor-1 in Bladder Cancer
    Chai, Jiagui
    Yin, Sifan
    Feng, Wenbo
    Zhang, Tao
    Ke, Changxing
    CURRENT MOLECULAR MEDICINE, 2024, 24 (07) : 827 - 834
  • [30] Targeting hypoxia-inducible factor-1 for therapy and prevention
    Zhong, H
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (07) : 951 - 966